Blog

  • Malaysia to Enact Age Restrictions this Year

    Malaysia to Enact Age Restrictions this Year

    Photo: Heorshe

    Malaysia will restrict the sale and purchase of tobacco products and tobacco substitutes to those aged 18 and over this year, reports The Star.

    Lawmakers have been alarmed by rising rates of vaping among underage consumers.

    The recent National Health and Morbidity Survey revealed that the rate of cigarette use among adolescents aged 13 to 17 dropped from 13.8 percent in 2017 to 6.2 percent in 2022. For vaping, however, it increased from 9.8 percent in 2017 to 14.9 percent in 2022.

    “This is a wake-up call. The regulations (of the Act) will be enforced to curb this,” said Health Minister Dzulkefly Ahmad at the World No Tobacco Day Carnival in Kuala Lumpur June 2, 2024.

     The war on smoking requires a whole-of-government, whole-of-society approach, he added.

     “This includes non-governmental organizations, teachers, retailers, politicians and enforcement bodies, as well as Malaysians in general. We must be united in curbing the smoking and vaping culture,” he added.

  • French Tobacconists Oppose Price Hike

    French Tobacconists Oppose Price Hike

    Photo: OceanProd

    French tobacconists have objected to a proposal to raise cigarette prices to €25 per pack by 2040, reports Euractiv.

    Cigarettes in France currently retail for around €12.50 per pack, one of the highest rates in the Organization for Economic Cooperation and Development. In Europe, only U.K. and Irish smokers shell out more for their cigarettes.

    Despite the high price, France remains one of the countries with the highest number of daily smokers, and every year tobacco causes 70,000 premature deaths.

    To address this issue, the Senate Social Affairs Committee in a recent report suggested doubling the price over the next 16 years.

    Noting that “the policy of reducing smoking has failed,” the committee recommended increasing the price by at least 3.25 percent every year between now and 2040. According to the Senate, the prevalence of smoking decreases when the price increases by more than 4 percent.

    The Confédération des buralistes, which represents the interests of tobacconists in France, condemned the proposal, arguing that French already leads the way in terms of tobacco taxation. The group said the report disregards the consequences of price, both on the country’s public health and on the network’s economic situation.

    For tobacconists, efforts should focus on the fight against the black market, which account for between 30 percent and 40 percent of cigarettes consumed in France.

    However, this figure is disputed by anti-tobacco association ACT, the directorates of public finances and customs, Observatoire français des drogues et des tendances addictives, who put the figure at around 6 percent.

    France’s 2023-2027 National Tobacco Control Plan, presented in November by former health minister Aurélien Rousseau, currently plans a price of €13 per pack by 2026.

    The EU is likely to review tobacco taxation following the EU elections in June, as the current Commission has not reviewed the 2014 Tobacco Products Directive and the 2011 Tobacco Taxation Directive, as originally planned.

  • Namibia to Regulate E-cigarettes

    Namibia to Regulate E-cigarettes

    Image: sezerozger

    Namibia plans to regulate vapor products and water pipes, reports the Windhoek Observer.

    The country’s Ministry of Health and Social Services wants to amend the Tobacco Act to include those products.

    The goal is to curb the growing use of electronic cigarettes and water pipes across the country. The amendment will also facilitate the development of a comprehensive tobacco strategic plan scheduled for launch later this month.

    Deputy Minister of Health and Social Services Ester Muinjangue stressed the urgency of regulating vaping products, despite existing legal frameworks to combat tobacco use in Namibia. “There is no safe form of tobacco smoke,” she said, rejecting suggestions that vaping and hookah smoking are safer alternatives to traditional cigarette smoking.

    Muinjangue encouraged smokers seeking to quit their habit to utilize existing resources and seek support from health professionals.

  • Bhutan’s Tryst with Health Imperialism

    Bhutan’s Tryst with Health Imperialism

    The author standing with a local in front of a pharmacy stocking NRT gums adjacent to a grocery shop officially selling tobacco. (Photo courtesy of Sudhanshu Patwardhan)

    Without offering locally relevant cessation tools, prohibition is doomed to fail.

    By Sudhanshu Patwardhan

    Bhutan, a country that measures its riches in terms of “gross national happiness,” may have become an unsuspecting victim of a new form of imperialism: health imperialism. A blind copy-paste of Western tobacco control policies, worsened by local gold-plating, may have landed Bhutan in a mess. A visit to the landlocked nation gave the author a unique insight into how prohibition of tobacco without offering locally relevant and innovative tobacco cessation tools threaten this Shangri-la.

    The Forbidden Kingdom

    A series of district-wide tobacco control measures in Bhutan from the 1980s culminated in the declaration of a nationwide ban on the sale of tobacco products in 2004 through a resolution of the National Assembly. Overnight, Bhutan became a poster child of global tobacco control, an emerging David against the Goliath of transnational tobacco companies. Nanny statists got a lifeline, and the “p” word—prohibition—was resurrected after successive failures of over 150 years in alcohol and drug prohibition movements. The Tobacco Control Act of 2010 further enshrined into law restricted access, availability and appeal of tobacco products and gave sweeping powers for arresting those selling or even possessing tax-unpaid tobacco for personal consumption. Bhutan was all set to become a tobacco-free society. A happy nation was also going to become healthier. In theory.

    Market Forces Take Over

    The roller-coaster ride between 2010 and 2019 is captured in the World Health Organization’s regional office’s 2019 publication The Big Ban: Bhutan’s journey toward a tobacco-free society. A big achievement in this period was visible reduction in public place smoking. Otherwise, the optimistic title belies the details of the failed ban confessed in the publication. It is a classic tale of good intentions scuppered by poor execution. A highlight of the data reported there is the difficulty in enforcing the ban, evidenced by availability of tobacco products below the counter in most shops in Bhutan. Tobacco use among 13-year-olds to 15-year-olds went up from 24 percent in 2006 to 30 percent in 2013 based on the Global Youth Tobacco Survey findings. The severe penalties required by the initial law resulted in more than 80 people being imprisoned between 2010 and 2013. There was growing discontent about the disproportionality of the penalties among the people of a nation gradually moving from a benevolent absolute monarchy to a democratic constitutional monarchy. Public furor and rethinking among the lawmakers resulted in amendments and milder punishments, and the law’s “claws (were) trimmed,” states the WHO report. Between 2010 and 2014, permissible quantity for personal possession was steadily increased for both smoked and smokeless tobacco products. The ban and its enforcement were proving ineffective and untenable. And then Covid-19 happened.

    Reversal of a Failed Ban

    The government was obviously losing revenue due to the flourishing black market of smoked and smokeless tobacco products smuggled from India and elsewhere. The fear of tobacco smugglers bringing in the Covid-19 virus was enough excuse to act decisively. In July 2021, the government amended the 2010 Act, thus lifting a decade long ban on local tobacco sales.

    The pragmatism of the politicians who reversed the ban presents a sharp contrast to the previous prohibitionist policy. Today, sales and consumption continue, and based on the most recent (2019) WHO STEPwise approach to surveillance (STEPS) data, 24 percent of those between ages 15 and 60 currently use tobacco products. Sadly, the ban did not make Bhutan a tobacco-free society. Anecdotally, e-cigarettes are also available now in some grocery stores in the capital, Thimphu, and attracting use among smokers and never-smokers. These are not regulated nor used as smoking cessation tools, presenting another area of concern for public health. A ban may not be the answer for these products either. Regulation that balances current smokers’ needs for safer alternatives versus prevention of uptake by the youth and nonsmokers will be key.

    Peering Through an ‘Addiction’ Lens

    I first read about the ban’s overall failure in the 2019 WHO report and then heard about the reversal of the ban during the global Covid-19 pandemic. How did Bhutan land in this situation? There is, of course, economics at play: demand, supply and something to do with a genie being out of the bottle. When I put my doctor’s hat on, a key explanation stares at me: lack of quitting support for the existing 120,000 tobacco users. Reams of self-congratulatory publications and numerous WHO awards to Bhutan since the 1990s have focused on success in awareness-building and restricting access and use. The famous case of the Buddhist monk who was jailed for three years in 2011 for the possession of $2.54 worth of tax-unpaid tobacco misses the point that he was very likely addicted to tobacco and may have needed more than punishment to quit. In the absence of availability of tobacco products, it should have been a human right for him to have access to safer nicotine to manage nicotine withdrawals and achieve craving relief. This assessment should not be used to vilify tobacco users. Instead, it should be a reminder to those in tobacco control that preaching to nicotine-dependent users without offering alternatives is not enough and also unethical. A key demand-side reduction measure, to use Framework Convention on Tobacco Control (FCTC) vocabulary, is that of providing tobacco dependence treatment and services. This is covered under FCTC Article 14 but rarely implemented in low-income and middle-income countries (LMICs), Bhutan included. I saw firsthand recently the country’s struggles with rising tobacco use coupled with a lack of cessation products and services.

    Tobacco Cessation: The Poor, High-Maintenance Cousin

    In Bhutan, like in most LMICs, overall tobacco control is run by public health experts, and tobacco cessation specifically (and separately) falls under the remit of psychiatrists. Neither groups are excited by tobacco cessation for a variety of reasons. Public health professionals often have little or no experience in treating individual patients and have increasingly been sold a unidimensional narrative that the tobacco epidemic is singularly driven by the commercial vested interests of tobacco companies (the “vector”). For them, the tobacco user is a victim of the tobacco industry, should be labeled an addict and then preached at to quit. Psychiatrists, on the other hand, are generally geared toward treating established mental health conditions and severe mental illnesses and even within the “de-addiction” field prioritize substance abuse treatment and alcohol de-addiction over tobacco cessation. Tobacco cessation with nicotine-replacement therapy and other pharmacological interventions are costly and need a level of training and qualification to prescribe—and are therefore cost-prohibitive to be offered at scale. They are also not without their failures, give around 20 percent quit rates at one year in controlled clinical studies and much less success in real-world settings. The success of quitting cold turkey is overrated and often drives policymakers’ wrong beliefs and attitudes about the ease of quitting. Public health tobacco control awareness campaigns and advocacy, on the other hand, are highly visible, scalable, inherently worthy endeavors, and most do not require impact assessment as proof of success. The FCTC’s Article 14 thus remains a neglected tool for reducing harms from tobacco globally and receives little or no funding from international donors and national governments nor any interest from pharmaceutical companies or tobacco companies to innovate in.

    Safer Nicotine Not Widely Available in Bhutan

    Nicotine illiteracy among healthcare professionals and lack of availability of safer nicotine alternatives can translate into poor quitting among tobacco user patients. From my field visits to pharmacies and discussions with frontline healthcare professionals in Bhutan, I noted that 2 mg and 4 mg nicotine gums have only recently become available in some pharmacies in Thimphu, but patches are not stocked. Patients come and buy these over the counter, but there is little record of how long they take it for, their quit and relapse rates and whether their doctors support them in their quit journeys. Varenicline or bupropion are not available for cessation. When called, the “national quitline,” contrary to the claim of the 2019 and 2024 WHO publications, do not deal with tobacco cessation support. Most of the healthcare professionals in Bhutan receive their undergraduate and graduate training in India, Sri Lanka and other nearby Asian countries. Similar to the rest of the world, doctors in Bhutan are not confident about prescribing nicotine-replacement therapy and may harbor misperceptions about nicotine itself. They have not received any tobacco cessation-related training in the past five years, and nicotine-replacement therapy is not available for free or at subsidized prices anymore, unlike other medications in Bhutan.

    Navel-Gazing Time for All?

    The backpedaling by Bhutan on the tobacco ban has not been reported or analyzed widely enough. Bhutan’s failure to rein in tobacco sales and increased use, despite a ban, should be a wake-up call for all parties involved. What was touted as a role model for other countries for eliminating harms from tobacco has instead become a cautionary tale for poor policymaking done to pander to international funders and organizations. The undue influence of a select few Western nations in national health policymaking for LMICs is also a matter of concern as the global geopolitical order rapidly morphs. Projects such as FCTC 2030, funded by the U.K., Norway and Australia, continue to churn out reports such as the Investment Case for Tobacco Control in Bhutan (WHO/UNDP, February 2024), ignoring lessons from the ban, mostly unaware of capacity issues on the ground and not addressing the need of current tobacco users for safer nicotine alternatives. Emergent strong economies such as China and India will no longer tolerate meddling by past colonial powers and imperialist nations in their health policies, but neither should other LMICs.

    Toward Gross National Health

    For a nation of around 750,000 people, tobacco use is claimed to kill between 200 people and 400 people every year—all preventable deaths (side note: the data for the same year varies dramatically between two WHO reports). Global tobacco control has failed Bhutanese tobacco users and their families. For a nation built on principles of sustainability, risky forms of smoked and smokeless tobacco products have no place in society. The mountains, the clean air, the happy smiles and peace-loving people of Bhutan deserve to own tobacco control initiatives, not be made to adopt hand-me-down Western ideologies or policies. That will require the doctors and pharmacists in Bhutan to understand the science of tobacco cessation and harm reduction and make quitting sexy. Availability of nicotine-replacement therapy products, innovation in safer nicotine alternatives and improved cessation services will need to be ensured and incentivized by the government. That has the potential to keep their nation happier and healthier for the coming generations.

    Disclaimer: The author’s work here or elsewhere is dedicated to using ethical and scientific evidence-based approaches to eliminate harms from all risky forms of smoked and smokeless tobacco products. The article is based on the author’s personal conversations with experts and lay people in Bhutan and from shop visits and an analysis of two of the most recent WHO reports on this topic. The intent of this article is to shine a light on a vulnerable LMIC’s experience with unchecked health imperialism to create insight and debate on the impact and implications of such practices. The author holds utmost respect for the nation, the policymakers and the people of Bhutan.

  • Heated Breakthrough

    Heated Breakthrough

    Greentank is at the forefront of innovation with the launch of its patented Heating Chip technology.

    By Timothy S. Donahue

    The vaping industry is in a constant state of innovation, primarily driven by advancements in hardware. A significant focus has been on enhancing battery quality as well as the electronics and circuitry within vaping systems. Notably, there have been substantial advancements in atomization technology. This includes the development from traditional wire coils and wicks to a more progressive adoption of ceramic materials.

    Atomization technology is crucial because the heating element functions as the core of a vaping system. The coil’s role in atomizing e-liquid is pivotal; the more efficient the element, the better the aerosol production, consistency and flavor. Recently, a leading technology company announced its breakthrough in heating technology, set to revolutionize the market.

    It has been seven years since a significant advance has been made in atomization technology. Enter Greentank: a company with a wholly new design representing a dramatic step-change from the conventional ceramic and wicked coil systems prevalent in many of today’s vaping products, promising enhanced safety, performance and experience.

    Greentank is a business-to-business technology company that specializes in the design, development and manufacturing of precision-made inhalation devices and atomization technology, according to CEO Dustin Koffler. Greentank’s latest innovation in atomization is called Quantum Vape. It replaces cotton wick and ceramic heating elements with a state-of-the-art patented Heating Chip.

    According to Koffler, the Heating Chip outperforms all other leading atomization products. For example, the Heating Chip performs better on key safety metrics such as harmful and potentially harmful constituents (HPHCs) and heavy metal testing than other leading technologies in the market. It also produces the “absolute greatest” release of flavor and the most consistent consumer experience from the first draw to the last, he says.

    “With this breakthrough in inhalation science, we’ve catapulted beyond the current generation of atomization technology,” said Koffler. “Our Heating Chip is set to disrupt the global market. It’s a distinct departure from anything currently available. While many companies focus merely on tweaking the substrates and print materials used in ceramic-based systems, they remain bound to the same ceramic foundation.

    “They’re refining ceramics—making components slightly smaller, slightly tighter, experimenting with new materials and formulations. Greentank, however, is pioneering an entirely novel approach that’s unlike anything witnessed in the industry before.”

    The Heating Chip is small. It comfortably fits on a fingertip and is one-fifth the size of today’s heating solutions. However, Koffler said its high-performance standards are due to advances that have never been achieved before with atomization. Typically, in a ceramic heating element, over time, flavor starts to dissipate naturally. This is because there is caking or buildup inside the pores of the ceramic, causing the temperature throughout the ceramic to vary after each use, leading to thermal cycling. With the Heating Chip, there is zero potential for thermal cycling, according to Greentank; every puff tastes the same as the first.

    “The Heating Chip employs a unique capillary action to draw the oil through the heating element, ensuring that each puff initiates a fresh cycle of material,” explained Koffler. “Many products boast consistent flavor throughout use, yet we’re all aware that the current market offerings fall short in maintaining this throughout the life of the product. In contrast, the Heating Chip integrates nanofabrication into its design.

    “The entire manufacturing process is proprietary, involving novel methods to assemble materials into the Heating Chip that emits no ceramic particle emissions and contains the lowest levels of harmful and potentially harmful constituents. While it’s not feasible to claim complete absence, third-party testing and rigorous chemical analysis have found these HPHCs to be at undetectable levels.”

    Additionally, Greentank only recently completed a longevity study using the Heating Chip in one of the company’s proprietary electronic nicotine-delivery system devices with a target of 15,000 puffs. “We easily achieved this target while demonstrating consistent vapor output from the first puff to the 15,000th puff,” explained Koffler. “Furthermore, we provided these same devices, along with new ones, to Labstat International to conduct aerosol analysis for both carbonyls and metals. The results showed that there was no difference in the safety efficacy from the first puff to the 15,000th puff.”

    Technically Speaking

    To a scientist, it’s a micro channel-based aerosol generator that delivers sub-micron particles according to its proprietary design. To the average consumer, it’s a smoother experience with maximum flavor intensity in a less-risky delivery than currently marketed e-cigarette and cannabis vape products. The Heating Chip isn’t anything like ceramics, said Koffler. Porosity isn’t inconsistent. It’s a chip with thousands of small holes and microchannels that allow for a superior level of precision and control in the atomizing process.

    One of the major challenges in designing the Heating Chip was finding the right talent to help develop the manufacturing process, said Koffler. The manufacturing of the Heating Chip requires specialized equipment, and bringing together a system that worked was incredibly complicated. The manufacturing of the Heating Chip can be compared to producing semiconductors.

    “By adapting pioneering techniques from other advanced industries and tailoring them to meet our specific requirements, we’ve enhanced our technology’s performance,” Koffler revealed. “The expertise of our global team, the precision of the equipment we utilize and our methodical focus on perfecting one aspect of the process at a time has been instrumental in overcoming the challenges we faced.”

    The next generation of atomization technology is moving away from ceramics, according to Koffler. The Heating Chip technology avoids all heavy metal leaching and ceramic particle emissions and ensures the lowest HPHCs all while permitting an unprecedented taste and consistency over a longer lifetime.

    It also offers a smoother experience and better mouth dispersion. Interestingly, the device is also able to create particulate matter small enough to reach lower lung absorption levels for nicotine, much like combustible cigarettes. This could be a giant innovation in getting smokers to adapt to less risky nicotine-delivery systems.

    “Utilizing microfluidic channel technology, we’ve engineered a system that precisely controls aerosol nucleation and optimizes particle size, enriching the sensory experience while maximizing intensity without any harshness,” Koffler detailed. “Our design includes independently arranged channels and a thin film interface that safeguards against chemical reactions and thermal decomposition. This architecture not only enhances flavor fidelity and ensures consistent temperature but also elevates safety standards and reduces potential harm significantly. From the outset, our goal was to achieve unparalleled performance and safety.”

    The size of the Heating Chip is incredible. It’s tiny. It’s one-fifth the size and 100 times the precision of any ceramic atomizer on the market today, according to Koffler. Its reduced size creates greater design flexibility and quicker response times. The Heating Chip is produced on sophisticated micro- electromechanical systems (MEMS) machinery. MEMS is a general term for forming a micron-level three-dimensional structure on a support substrate such as a silicon wafer and integrating functions such as electronic circuits, sensors and actuators.

    “Unlike the broad, imprecise methods typical of ceramic manufacturing, our approach from start to finish is meticulously controlled and exact,” explained Koffler. “This precision is why developing the right equipment for producing the Heating Chip was an extensive process. The level of control we achieve with the MEMS technology not only enhances consistency but also opens up revolutionary possibilities in precise dosing for pharmaceutical applications. This capability to finely tune dosages is a game changer in both vaping and medical fields.”

    Future Markets

    Based in Toronto, Canada, Greentank doesn’t produce nicotine. It doesn’t manufacture e-liquids or cannabis products. At its core, Greentank is a technology and product development company with a focus on safety, performance and reliability. The Heating Chip is not made from ceramics. While the material is proprietary, Koffler insists the technology is something new and its application in inhalation products is only scratching the surface of its potential. It is designed specifically for multiple verticals, predominantly electronic nicotine-delivery systems but also pharmaceuticals and wellness products.

    “We have expanded to over 100 employees across Canada, the U.S., the U.K., Singapore and China, with the majority focused on research and development,” Koffler detailed. “We’ve assembled a highly skilled manufacturing team to produce our innovative chip and have strengthened our engineering and material science capabilities. Last summer, we acquired Numerical Design, a company specializing in microfluidics and microfabrication, boasting an extensive portfolio of patents that further strengthen our intellectual property. This strategic expansion underscores our commitment to leading the edge in technology and manufacturing excellence.”

    Greentank spent over three years developing and testing the technology surrounding the Heating Chip and its manufacturing process. Additionally, it has been created with a robust intellectual property portfolio involving more than 50 patent families to bring forward a variety of advancements. The company’s technology is manufactured in ISO-certified labs, and all products undergo third-party testing.

    The technology is completely different from what exists in today’s inhalation devices. It gives Greentank the flexibility to be adopted into various inputs and varying viscosities. For example, it works well with both low-viscosity water-based e-liquids and high-viscosity resin oils from cannabis materials.

    In March of 2023, Greentank announced that it successfully closed a $16.5 million Series B financing round led by a strategic investor group with more than 15 years of manufacturing experience. The total investment in Greentank to date is now reported at $38.5 million.

    “Our Series B funding was a strategic move to elevate our operations from industrial prowess to global commercialization,” said Koffler. “We’ve established a 20,000-square-foot cutting-edge R&D and manufacturing facility, a project that spanned 18 months to build and equip with the most advanced technology needed to scale our Heating Chip.

    “This facility not only pushes the limits of what’s possible with specialized equipment and expertise but is also designed with flexibility in mind. Our vision was to create a model that can be replicated anywhere in the world, preparing us to expand into any other market as we continue to grow our business.”

    The expansion of the business is about phases, and Koffler said that during the next phase, whether that be the medical or wellness industry, Greentank needs to be able to produce chips to meet global demand with scale in mind. Koffler said this means that the company will look to leverage automation.

    Koffler emphasized that the real measure of Greentank’s success will be seen as the next generation of inhalation devices hits the market. He highlighted that numerous devices are on the cusp of being launched, with the Heating Chip poised to redefine industry benchmarks for safety and efficiency. Currently, Greentank is aiming to influence tobacco harm reduction significantly.

    “At Greentank, our commitment extends beyond mere compliance with regulatory standards; we are dedicated to establishing new paradigms of transparency and consumer safety,” said Koffler. “We are not just participating in the market—we are leading it toward a safer and better future.”

  • Revenant Rule

    Revenant Rule

    Image: MarijaBazarova

    Canada’s new health minister is breathing new life into a 2021 proposal to ban vape flavors nationwide.

    By Stefanie Rossel

    Thomas Kirsop

    There’s life in the old dog yet: In March 2024, Canada relaunched a three-year-old plan to ban all vape flavors except tobacco, mint and menthol. The regulations were first published in June 2021 in the Canada Gazette, signaling the government’s intention to implement the flavor ban within six months after the obligatory public consultation. But the rule that was supposed to launch in January 2022 never came, and Canada’s health authorities never mentioned the flavor ban again—until Health Minister Mark Holland, in office since July last year, recently revived the idea.

    Outrage about the proposed ban among vapers, consumer advocacy groups and the vape industry was as huge in 2021 as it is now: Canada’s planned rule goes further than most flavor bans, which tend to prohibit only certain “characterizing flavors” or flavor descriptors. Under the Canadian proposal, all sweeteners in vaping products would be prohibited, and vape manufacturers would be allowed to create their liquids using only approved ingredients.

    They would have to select from a list of 82 approved compounds, 40 of which can be used to impart a tobacco flavor and 42 of which can be used to impart flavor of mint, menthol or a combination of the two. “Menthol tobacco” or a “mint tobacco” are off limits under the rules.

    “Should the flavor ban be adopted as it was written in 2021, Canadian users of vaping products will see the removal of nearly all existing flavor profiles in the legitimate vaping products market within 180 days of publication of the proposed order and regulation from 2021,” says Thomas Kirsop, managing director of Canada’s Vaping Industry Trade Association (VITA).

    “The only two products on the market that would not require removal or reformulation would be ‘unflavored’ liquids and unadulterated ‘menthol.’ All existing ‘tobacco’-flavored vaping products would need to be removed from the market, reformulated to remove sweeteners and flavoring compounds not on the permitted constituents list and then reintroduced to the Canadian market.”

    The proposed rule would also prescribe “sensory attributes standards,” which are defined only vaguely, stipulating, for example, that a vaping product or its emissions should not have “sensory attributes that result in a sensory perception other than one that is typical of tobacco or mint/menthol,” thus limiting manufacturers’ ability to make vape products that have “a highly pleasant smell or taste.”

    “Sensory attributes regulations are referenced over 40 times in the proposal, but there is no specific section explaining how these regulations would be drafted, implemented or enforced in a clear manner,” says Kirsop. The VITA interprets this part of the planned regulation as meaning that manufacturers can make their liquids using the 82 permitted compounds, and at some time in the future, the government will pay a third party to smell, taste and possibly vape this product. “If that third party thinks that the liquid does not align with the permitted flavor profiles or is ‘too palatable,’ then that formulation will be prohibited regardless of its adherence to all the objective standards in legislation,” says Kirsop.

    Relapse to Combustibles Expected

    The impact of such a regulation on Canada’s 1.5 million vapers would be dramatic, according to Kirsop. His organization anticipates a major relapse to combustible cigarettes among consumers. “The number of cigarettes consumed per capita will increase,” he says. “It is well understood that vaping products and combustible products are economic substitutes in the nicotine market. A regulatory impact on one will result in an inverse reaction of the other.”

    Kirsop refers to a 2023 study by Abigail Friedman that investigated the effects of e-cigarette flavor restrictions on tobacco product sales in the U.S. and found that while the flavor restriction did impact vaping rates in the manner intended, the impact on legitimate cigarette sales was substantial, with 12 extra cigarettes sold in the legitimate market for every 0.7 mL pod not sold due to a flavor ban. The VITA has similarly calculated that a nationwide flavor ban in Canada would result in additional cigarette sales of almost 4 billion sticks per year.

    For the country’s independent vape manufacturers and estimated 1,800 specialty vaping product shops, such a measure would have a significant, possibly existential, impact, according to Kirsop. “It is the variety of flavored vaping products that make a specialty store economically viable,” he says. The illicit market, by contrast, would receive a boost, especially if the flavor ban comes on top of the 12 percent federal vape product tax hike planned for July.

    “From any historical reference point, the removal of a product with significant consumer demand from the legitimate market will result in that demand being met by the illicit market,” says Kirsop. “Our investigations lead us to believe that the black market will expand quite rapidly to fill the void. Our only question is whether that illicit trade will favor small players, producing flavored liquids in garages and basements, if it will follow the Australian model, with organized crime groups importing flavored disposable vaping products from overseas, or if it will be some hybrid combination of both.”

    There are plenty of cautionary examples close to home. Six of Canada’s 13 provinces and territories have already restricted the sales of e-cigarettes to tobacco-flavored varieties. “In Nova Scotia, over 40 percent of specialty vape stores closed immediately following the flavor ban, and when VITA commissioned an investigations company to survey the market, we found significant illicit trade and a consumer outlook that supported that illicit trade,” says Kirsop. “News reports showed that in the year after the flavor ban, tobacco excise collection increased 13.6 percent. We also identified that consumers are starting to adapt by adding their own third-party commercial flavoring products to vaping liquids.”

    Goal Missed

    Maria Papaioannoy

    Kirsop says it’s too early to determine the impact of flavor bans on youth usage. However, the VITA has found no data that differentiate Nova Scotia, which was the first province to ban flavored vaping products, from provinces that kept them on the market or banned them at a later date. “Nova Scotia shows youth past-30-day vaping behavior has dropped from 25.1 percent to 23 percent since their flavor ban,” says Kirsop. “However, all provinces except Quebec saw youth vaping rates drop in the same category during that time frame, and some of them did significantly better. Alberta saw youth use drop from 19.9 [percent] to 14.8 percent, British Columbia 27.6 [percent] to 16 percent, Manitoba 21.5 [percent] to 16.7 percent and Saskatchewan 29.6 [percent] to 23.7 percent. All the latter have no bans on flavors.”

    So, while the intended impact on adolescents remains questionable, the effect on adults would be devastating, according to Maria Papaioannoy of Rights4Vapers. “Flavors are a critical part of what makes vaping such an effective alternative to cigarettes,” she wrote in a letter to Prime Minister Justin Trudeau. “If a person who smokes decides to move to vaping, they do not want to be reminded of the taste of tobacco.” A ban on flavors as proposed, she argues, would mean a prohibition of the entire category through the back door. “Who would pay for an unpalatable product?”

    In 2021, Rights4Vapers started a letter-writing campaign, resulting in more than 20,000 Canadians submitting arguments to Health Canada against the proposed regulation. Papaioannoy has organized a similar campaign now. To date, the government has received more than 27,000 letters from adult consumers raising concerns over this ban. In mid-March, Papaioannoy spoke at Health Canada’s stakeholder meeting but left disillusioned. “Consumers had a huge voice in vaping regulation with previous health ministers,” she says. “In this call, all I felt from Health Canada representatives was sympathy, not compassion.”

    Like many, Papaioannoy believes that the proposed flavor prohibition is not so much an action of bureaucracy but a mandate being driven by Holland, who formerly worked for the nongovernmental organization Heart and Stroke, a known opponent of vaping.

    Both tobacco harm reduction activists hope that as lawmakers debate the measure, reason will prevail. “The wild card is the minister of health,” says Kirsop. “Generally, one would think that policy decisions that could impact millions of Canadian smokers and 1.5 million adult Canadian users of vaping products would be based on scientific data and academic literature and not driven by emotional talking points and flag waving.

    “This minister has demonstrated that he has no grounding in literature or the science, and it does not appear at this point that he cares much for it if it does not align with his ideology or that of his former peer group. Ideology forms a very poor starting point for public health decisions.”

    Papaioannoy is more optimistic, noting that the proposal still has to go through the Treasury Board of Canada, with the time frame between proposing and enacting being long and opposition strong against a measure that would affect small businesses. “Besides, I believe in the institution,” she says. “Someone from the government will raise the flag.”

  • BAT Still Committed to Smokeless Future

    BAT Still Committed to Smokeless Future

    Josh Fett (Photo: BAT)

    On World Vape Day (May 30), British American Tobacco outlined a strategic vision to accelerate progress toward building a smokeless world, especially for the Asia-Pacific region, to encourage adult smokers to switch to smokeless alternatives such as vapor products.

    The smoking prevalence among adults in the Asia-Pacific region is amongst the highest in the world, though it continues to fall each year in some markets. However, with various governments setting goals to be “smoke-free” (defined as smoking prevalence falling to 5 percent or less), BAT says that more must be done to realize their ambitions.

    In its vision, the multinational sets out four principles that it believes should be applied for effective and impactful regulation relating to smokeless tobacco and nicotine products:

    1. Access to consumer relevant products: regulations in all countries where cigarettes are sold should also allow a wide range of smokeless alternatives to ensure that consumers can access these alternatives and make informed choices about switching based on the best available scientific evidence.
    2. Adult-only consumer: the use and sale of smokeless tobacco and nicotine products by and to the underage should be prohibited by law.
    3. Product quality and safety: robust and properly enforced quality and safety standards should be at the heart of regulation, to protect consumers.
    4. Robust enforcement: Regulation should provide enforcement authorities with the necessary powers to apply penalties and sanctions to those who fail to comply with regulations, particularly those who supply non-compliant products and provide product to those who are underage.

    “More than 1 billion people globally continue to smoke despite the serious risks,” the company wrote in a statement. “According to population modelling studies, a significant reduction in premature deaths could be achieved if smokers switched exclusively to reduced-risk alternatives.

    “To capitalize on the public health potential offered by smokeless products, appropriate regulation is required to encourage adult smokers to switch, protect consumers with stringent safety standards and prevent underage access and use.”

    BAT noted that countries that embraced this approach have witnessed significant reductions in smoking rates as smokers opt for noncombustible products. The multinational cited the experience of New Zealand, where daily smoking rates have plummeted to 6.8 percent in 2023 from 8.6 percent the previous year, and 16.4 percent in 2012. The U.K., U.S. and Japan too are reporting their lowest smoking rates on record, while Sweden is on track to declaring itself smokefree this year, 16 years ahead of the 2040 EU target.

    According to BAT, the success of these nations in reducing cigarette consumption is largely a result of widespread awareness, availability and usage of smokeless alternatives, such as vapor products, heated products and nicotine pouches.

    “The migration of smokers to these alternatives is crucial both for countries looking to reduce their smoking rates and for global public health more broadly,” said Josh Fett, BAT’s head of corporate and regulatory affairs in the Asia Pacific Region. “Whether or not governments are able to take advantage of these products and maximize their harm reduction potential depends as much on the implementation of progressive, risk-proportionate regulation as it does on changes in consumer behavior.”

  • Passing the Torch

    Passing the Torch

    SPI Development’s new building the has enabled the company to bring together people working on similar aspects of the company’s business within discrete areas, while facilitating communications and increasing comfort. | Photo: SPI Development

    Danielle Roxborough takes the helm from Henry Tuck as SPI Developments enjoys a period of steady growth.

    By George Gay

    Danielle Roxborough

    Talk to a lot of people, especially those not working within the tobacco industry, and they will tell you the industry is in decline. They will tell you that smoking rates are falling in many markets and plummeting in some others. And there is truth in this, though it raises a question about how, for instance, the U.K.-based fluids control company, SPI Developments, which is heavily involved in the industry, has been expanding and is expecting to continue to expand. But SPI’s managing director, Danielle Roxborough, has a rather neat explanation for this apparent enigma. The tobacco industry had not declined, she told me in April; it had been shaken up, and, consequently, a lot of new opportunities had been exposed to the light.

    I was speaking on the telephone with Roxborough and Henry Tuck during a management transition period when she was still business development manager and managing director designate and he was preparing to stand down as MD on May 31.

    In his own way, Tuck endorsed Roxborough’s view of what had happened, saying that since joining BAT and starting what was to become a 40-year career in engineering, mostly in the tobacco industry, he had seen the consolidation of the industry’s manufacturing base but an expansion of its products. What had been an industry concentrated on producing traditional tobacco cigarettes that were largely unchanged over decades was now also producing a range of new generation products that were being frequently updated and replaced. The life spans of these new products were short, Tuck noted, and every new iteration came with potential opportunities for SPI.

    While SPI has always had a good foothold in flavor application equipment, this year has seen a major increase in orders.

    Vote of Confidence

    That SPI, which is part of the Tembo group of companies, has confidence in the future was underlined about six months ago when it moved within its hometown of Rotherham, Yorkshire, into a new building that Roxborough described as being “expansion proof.” The new facility has allowed the coming together of SPI and its subsidiary A1, which is responsible for machining components for SPI’s equipment. The two companies used to operate from premises on opposite sides of the road on which they were sited but are now housed together in a single unit that provides more space for all aspects of the company’s operations.

    To give an idea of the size of the new premises and what the move means, Roxborough explained that whereas previously, space limitations had meant that engineers had struggled to build even a single RWM, the company’s biggest machine that applies menthol to the tissue side of foil bobbins, earlier this year, they had built three simultaneously. In addition, the new space had allowed what Tuck described as significant investments to be made in new turning and milling machinery, which space limitations would not have allowed previously. All in all, what these developments added up to was an increase in productivity and a reduction in lead times.

    The move has also allowed the bringing together of people working on similar aspects of the company’s business within discrete areas but also an improvement in communications between those areas, a general increase in comfort and a consequent boost in morale. And, of course, there are the intangibles. Tuck said that the building had given the company a bigger, more professional feel while Roxborough reflected on how the new building’s glass frontage provided much natural light, saying, “it is amazing what it can do for your day.”

    Cross-Fertilizations

    As well as operating out of a new facility under a new MD, SPI has a relatively new designation as a fluid control company, something that stems from its status as the fluids expert within the Tembo group, from the business cross-fertilizations provided through cooperating with other members of the group and from the need to keep abreast of the expanded requirements and horizons thrown up by the arrival on the market of modified cigarettes and new generation tobacco and nicotine products. Roxborough said that whereas most of SPI’s equipment was concerned with the application of adhesives and flavors to cigarettes, filters and heat-not-burn (HnB) products, the company now found itself involved in projects and R&D efforts involving different fluids, either within or without the tobacco industry.

    An example of the way in which the cross-fertilization of ideas can be exploited occurred some time ago when it was realized that a spiral-wound and glued paper tube being developed for an HnB project had basically produced a prototype paper drinking straw at a time when the EU was looking to ban single-use plastic drinking straws. And a bigger project has seen SPI involved with a sister Tembo company in detergent dosing systems for detergent pod manufacturing machines.

    Drivers of Demand

    But the focus is nevertheless on the tobacco industry, where a major driver of demand has been the need in some markets to replace cellulose acetate filters because of regulatory requirements and/or environmental concerns. Whereas the technology governing the production of cellulose filters has been largely standardized for some time, that for the current major alternative, crimped-paper filters, is still evolving, so SPI finds itself working with customers on different methods of applying various fluids to paper filters to help reproduce the taste generated through cellulose filters, to which smokers have become accustomed. In the future, such projects will likely widen to take in materials other than paper.

    Another driver is being provided by HnB products and the fact that increasing numbers of companies are producing their own versions. Tuck said that while traditional cigarettes were fairly standard and so the technology used to manufacture them was standard, in the case of HnB products, companies were being innovative and including different materials. Product lifetimes could be as short as three years or four years, after which it was a matter of working with the customer on the next iteration as part of an ongoing process. This manner of working represented a fundamental change from that which had guided the traditional tobacco product industry.

    But while the need to work in new ways with new materials is driving additional demand, the fundamentals of SPI’s business keep going. Roxborough said that while SPI had always had a good foothold in flavor application equipment, this year had seen a major increase in orders. And there had been solid demand, too, for upgrades of glue application systems.

    Manageable Growth

    Roxborough, who studied communications but who has filled commercial roles since graduating from university, has spent her 22-year career working with engineering companies, almost entirely those serving the tobacco industry. She has been with SPI for more than nine years and admits to being passionate about the company—a passion that tips over into confidence about the future. Joining the Tembo group had been hugely positive for the company, providing it with the opportunity to grow at a manageable pace, she said. And looking to the future, SPI and A1 had a great team of about 30 U.K.-based employees, including designers and engineers who could react quickly to new challenges emerging in the field of fluid control. At the same time, it could call on the resources of other Tembo group companies around the world.

    Although Tuck has now left the business after 18 years, Roxborough is not short of experienced support. Paul Leverick, who Tuck described as a “fantastic engineer” and who is the founder and chairman of SPI, is still in place, ready to mentor the younger engineers and the management team. It was Leverick and Tuck, the shareholders of SPI, who realized that the long-term future of SPI lay with ITM, later to become the Tembo group, and who sold it when that opportunity arose in 2018.

    Taking Hurdles in Stride

    They also helped steer the company through Brexit and the Covid pandemic. Tuck was reluctant to spend much time talking about Brexit, but it was clear from what he did say that he was not a fan. Brexit, he said, had cost SPI time and administrative effort, but the company had nevertheless taken these hurdles in its stride and would continue to do so—because EU legislative changes would be ongoing and would continue to have an impact on any company such as SPI that exported to the EU.

    In respect of the pandemic, the decision was taken early on that it was not viable for everybody to go home, so the company kept going while taking measures to keep its people safe, including by allowing those who were able to do so to work from home. In the end, the pandemic had little impact on the business, apart from the adjustments that had to be made to introduce the remote installation of equipment.

    With the sale of SPI to the Tembo group, the Covid pandemic, Brexit and the move to the new building, the past six years have been busy, but then so were the previous 12 years. When Tuck joined SPI as MD in 2006, the company had only four other employees, and it offered only PVA glue systems and a simple flavor application system. Now it has 30 employees, a much-expanded equipment offering and is part of a multinational group.

    Looking back, Tuck described working in the tobacco industry as being very interesting. As an engineer, he had found it “technically amazing” while the opportunity to travel the world had been mind-expanding. He would remember the industry as comprising a group of people who were open and welcoming.

    Finally, Tuck said that one of his more recent goals had been to move the company into a new building, and now that had happened. “I’m very happy with the management team; they are doing very well, and we have a good order book, so now is a good time to go,” he said.

    Leading the Livery

    Henri Tuck

    Although the accompanying story implies that Henry Tuck, until May 31 the managing director of SPI Developments, has left the tobacco industry, this is not strictly true. From June 5, he was due to have been elected and installed for one year as the master of the U.K.’s Worshipful Company of Tobacco Pipe Makers and Tobacco Blenders, of which he has been a member for about 10 years.

    Tuck, who used to have a long commute between his home and SPI’s premises, said that, since the Covid pandemic had struck, he had spent increasing amounts of time working from home, relying on the company’s management team for SPI’s day-to-day running. Basically, he added, he had been working himself out of a job and that, though he was shy of normal retirement age, it had made sense to leave in time to take on his new role, which would comprise a full-on year, chairing and running the livery company, and attending internal and external events in the city of London.

    The livery company has its foundations in the craft of clay pipe making, a craft that it is trying to keep going. There are two or three people left in the U.K. who make clay pipes for a small market comprising mainly those working in period films and dramas and those running reenactment societies. The company has a benevolent fund that helps various charities that fit its criteria, and within which is a welfare fund for former tobacco workers in the U.K. who have fallen on hard times.

    The company, which has close to 200 members, is one of 111 such companies in London that together donate about £75 million ($93.91 million) a year to charitable causes. Education, too, is a big part of the livery movement, and some companies have maintained traditional functions, such as supporting apprenticeships.

    It is worth noting that Tuck was introduced to the livery company by the person who preceded him as master, Elise Rasmussen, the founder and chief director of the GTNF (Global Tobacco and Nicotine Forum) Trust and vice president of sales and marketing at the U.S. Tobacco Manufacturers’ Association, which owns Tobacco Reporter. Tuck said that Rasmussen had been a great success in the role and that it would be hard to fill her shoes. She was known by everybody in the city and the livery movement. “Once met, never forgotten,” he said. G.G.

  • Pulling its Punches

    Pulling its Punches

    Photo: Christoph Burgstedt

    China, the world’s largest supplier of e-cigarettes, has failed to take full advantage of the risk reduction opportunities offered by vapes.

    By George Gay

    An Aug. 27 heading on a story in Singapore’s The Straits Times proclaimed, “300 million and counting: Why China just can’t kick the cigarette habit.” Newspaper headings are normally not written by the writers of stories and are aimed at grabbing the reader’s attention, but they should accurately reflect the story. In this case, however, there is a disconnect because whereas the story credits China with having an estimated 300 million smokers, nowhere does it say that number is rising, which I would expect given that the heading adds “and counting.” Indeed, the story does not claim that volume consumption is heading up, saying rather that such figures are not published.

    Another thing that immediately struck me about the heading was the use of the word “habit” rather than “addiction,” which seemed to suggest two things. One was that the story was not going to follow the course of many stories in other countries where the failure to end or significantly curtail cigarette smoking is put down to an inability on the part of authorities to force/encourage smokers to break their addiction despite their using methods that include everything from making cigarettes unaffordable through requiring manufacturers to degrade these products and insulting smokers in respect of their personal hygiene, to, if those smokers are lucky, encouraging the use of reduced-risk products in place of cigarettes. This story, the heading promised, was going to be about other issues.

    At the same time, the heading seems to question whether kicking smoking is a goal worth pursuing. After all, while the usual definition of addiction involves a compulsion that causes harm to the person indulging in the addictive activity, that is not the case in respect of a habit. After all, somebody might be in the habit of repeatedly looking at their mobile phone while supposedly out enjoying the company of a friend over coffee, which, of itself, is unlikely to cause them direct harm, though they might be in danger from the reaction of a sensitive but increasingly irritated friend sitting across the table, at least in polite societies.

    But hang on, the mood changes in the first sentence of the story, which reports that 20 years after adopting the World Health Organization Framework Convention on Tobacco Control [FCTC], “China is still addicted [my emphasis] to cigarettes.” Overall, the word “habit” occurs four times in the story and the word “addicted” twice. This might seem like a small point, but when the subject is what many people believe is the most preventable cause of disease and death worldwide, a reader should be able to expect that basic issues have been properly considered before going to print. English and, I guess, most other languages have what I would call vague words such as “habit” and “addiction,” which can be useful but which need to be used with caution, and clearly not where such vagueness can lead to confusion.

    I am not saying that it is not valid to use “habit” and “addiction” in reference to the same activity, but at least some attempt should be made to explain the distinction and to use the words, not as simple synonyms, but appropriately each time. I might be happy, for instance, to entertain the idea that for some people, smoking is an addiction that is difficult to break while for others it is a habit they can pick up now and again without becoming addicted, but I cannot accept that for the same individual, smoking can be both a habit and an addiction. 

    Muddled Thinking

    I worry that such issues are not considered properly, not only in the case of the The Straits Times but in stories published around the world every day of the week, something that leads to misunderstandings and pressure being put on politicians to enact unhelpful legislation. The public is served up stories that are beset with muddled thinking. We are told, for instance, in The Straits Times story that despite years of anti-smoking campaigning in China, people continue to smoke partly because cigarettes are cheap, there is a lack of public education, and Big Tobacco—presumably meaning the State Tobacco Monopoly Administration (STMA) and the China National Tobacco Corporation—is protected. But how is it possible to reconcile the claims that there have been years of anti-smoking campaigning when cigarettes are still cheap? The WHO and most other tobacco control bodies say that tax-induced cigarette price increases comprise the most important factor in getting smokers to quit. And there surely cannot have been years of anti-smoking campaigning without public education. I ask you, to whom was this campaigning directed?

    I am not saying that the claims are irreconcilable, but they do require some explanation. Is the reason that the extensive anti-tobacco campaigning has been unsuccessful down to the fact that China has followed FCTC policies that, overall, do not work, or that do not work in China, or is it the case that China, either intentionally or unintentionally, has not applied them properly?

    In fact, the story suggests that a major reason why anti-tobacco campaigning has had limited success is down to the power of the STMA and the pushback that it employs when anti-smoking policies are put forward, at least outside the biggest cities. I am happy to accept that this happens, but it does raise a question: Why did China sign up to the FCTC when it must have been aware that implementation of its policies was going to be resisted by a powerful state organization? The answer to the first part of the question, why did it sign up to the FCTC, probably comes within the wide-ranging category of “it seemed like a good idea at the time”—perhaps because at that time, China wanted to be seen as part of the international order, or maybe it was for some other, less obvious reason.

    The answer to the second part of the question is possibly more interesting. Could it be that China does not buy into all the negative publicity that surrounds tobacco? In many other parts of the world, the perceived wisdom is that tobacco is overall economically negative, but is this the case in China? Isn’t China, along, perhaps, to a lesser extent, with Brazil, something of a special case because its tobacco industry is highly economically active, from the tobacco fields, through manufacturing, to retail stores and throughout all the supporting industries and businesses that these activities imply? Frankly, it would be odd if China took the same attitude to tobacco as, for instance, the U.K., where there is no commercial tobacco growing and virtually no tobacco manufacturing. Differences in the healthcare systems of the two nations might also mean that economic calculations come up with different results.

    Could it be, also, that China does not buy into the tobacco health debate in the same way that many other countries do? In a world plagued by pollution, perhaps it finds it hard to accept the death toll normally attributed to tobacco smoking alone, as I do. I can think of other reasons why China might take a different view of cigarette consumption to that taken by some other countries, but I don’t want to encourage a sack full of letters of outrage, so I shall keep them to myself.

    A Missed Opportunity

    I am not saying that such thinking comes into play in China. In fact, I would be surprised if it does because, strangely, China seems to forge a tobacco path that is not that much different to the paths forged elsewhere and one where, certainly in places, it is aligned with the WHO’s de facto policies.

    Take reduced-risk products, for instance. One would have thought that in China, vapes would have comprised a powerful tool for allowing smokers to transition away from cigarettes—perhaps a more powerful tool even than it is in many other countries. I say this because The Straits Times story makes the point that smoking plugs into long-established social mores in China, one of which means that cigarettes are considered appropriate business gifts. Elegantly designed vapes would surely make acceptable—perhaps even better—alternatives in this regard and could be made to reflect the often-elegant, iconic branding of cigarettes.

    But China seems not to have taken full advantage of what vapes could offer it, which is especially odd given that, I assume, it is the world’s leading supplier of vaping devices. Rather, it seems to have fallen for the idea that flavored vapes, the vapes most effective in encouraging smokers to switch away from cigarettes, should be banned because they are attractive to young people.

    To me, this is the same sort of muddled thinking that crops up time and again in other countries. But at least it possibly provides an answer to the question implied by The Straits Times. Perhaps China will be able one day to break its cigarette “habit,” but, with one hand tied behind its back, it is going to take an awfully long time.

    But then the reporter from Singapore should understand this. Singapore, I think, once proclaimed that it would quit smoking by 2000, and that was in the days when “quit” meant just that, not reduce the smoking rate to 5 percent or thereabouts. Did it make that deadline? No; a quarter of a century later, it is still a work in progress, and it is likely to be so for many years to come. It likes to operate with two hands tied behind its back—it bans vaping outright.

  • Realists and Idealists

    Realists and Idealists

    Image: M-SUR

    We should celebrate ‘realists’ and beware of ‘idealists.’ Idealists do well in the rhetorical world of goal setting, aspirations and optics while realists do better in the real world. The problem is that the idealists obstruct the realists.

    By Clive Bates

    On April 22, the British Medical Journal and a new investigative publication, The Examination, funded by billionaire activist Michael Bloomberg, declared a victory. Their “investigation” had shut down a new continuing medical education program in smoking, tobacco and nicotine offered by the respected medical information provider Medscape. The course had been running for a few weeks and had proved popular with participants. It had been designed to address an essential unmet educational need: the widespread confusion among healthcare practitioners about the causes of disease, the nature of nicotine use and the options available to reduce the harms. It’s hard to imagine more valuable and actionable public health and preventative insights for practitioners. So why close it down? Simple: The initiative had been funded at arms-length by a tobacco company, Phillip Morris International, which played no role in developing the content.

    It’s worth pausing to examine what has been achieved here. The objection to tobacco company funding in the case is essentially aesthetic. To some activists, it just doesn’t look right. Tobacco companies involved in ending smoking? Weird! No one has presented material objections to the course content. I have no doubt that it was a sincere effort to raise the lamentable standard of medical knowledge in this area delivered by experienced professionals. The idealists were successful in burning this initiative to the ground. But here’s the point: Like arsonists, they didn’t build anything. They have left nothing where there was previously something useful. The activists have made their impassioned denunciations, expressed their righteous anger and moved on. But it’s an empty victory because the confusion and misinformation remain, and the opportunity to do better for the public and patients has been squandered. 

    I chose this recent example because it illustrates a more general problem with activism. The pursuit of idealistic goals is not necessarily heroic and may not be benign. It can make matters worse with real-world costs for people and the environment. Let’s take three examples from outside the nicotine field to illustrate the point, then return to nicotine. 

    First, the green opposition to nuclear power. In their quest for an idealist vision of a 100 percent renewable system based mainly on solar and wind power, greens have opposed a proven, reliable, low-carbon form of electricity generation. By creating fear and foreboding about nuclear risks, activists and regulators have made the technology exceedingly expensive and difficult to deploy, making fossil fuels relatively more attractive. The French experience from the 1960s shows successful large-scale nuclear deployment, but idealistic opposition has driven the costs upward since then. Finally, idealists are starting to feel the heat from the climate realists.

    Second, activists with an in-principle opposition to genetic engineering recently stopped the deployment of genetically modified golden rice, which is rich in Vitamin A, in the Philippines. Vitamin A deficiency is implicated in up to 500,000 cases of blindness in young children annually in Asia and Africa each year. Maybe it would be better to lift poverty and improve nutrition more systematically, but how long would that take, and how many people would be harmed waiting for the idealists’ more prosperous and just society? Like adding fluoride to water to protect dental health, golden rice would have added Vitamin A to the food supply system, creating widespread health benefits. Now, people will suffer instead.

    Third, local and international nonprofit organizations lobbied tenaciously for Sri Lanka to switch its agricultural system to become exclusively organic, backed up by a ban on the use of agrichemicals. They got their way, but it did not go well. The food supply crashed, the people went hungry and rioted, and the government fell.

    In each case, a noble aspiration, an eye-catching slogan or a grand commitment has stood in the way of making more mundane but pragmatic progress at the expense of human well-being. Some further characteristics are evident:

    • Idealists evade the messy and distinctly realist business of trade-offs, waving away the concerns of realists as a lack of ambition or “industry talking points.”
    • The idealists rarely accept accountability for the unintended consequences of their positions—the fault is with others for not trying hard enough or spending enough to match the idealists’ aspirations.
    • The idealists often receive an easy ride in the media, especially when they evoke youth to make their case. Did anyone ever put hard questions to Greta Thunberg?

    Turning now to the battle between idealists and realists in the world of tobacco and nicotine.

    First, the nicotine-free society. The idealists in tobacco control would like to rid us of this relatively benign recreational drug. Sorry, but that will not happen, and there is no reason why it should. People use nicotine because it makes them feel better, for its pleasurable, functional and therapeutic attributes. However, demonizing nicotine and treating all nicotine products as if they are equally harmful will obstruct the realists’ efforts to address the significant harm caused by smoking. The idealists take each ban and blockage of any nicotine product as progress to their larger goal. How else can we explain the sustained ban on snus in the European Union?

    Second, defending the purity of youth. Though all idealists have been teenagers at some point, few seem to understand them. Some young people have a propensity for risk-taking with drugs, alcohol, sex and other reckless behaviors, and yes, to use nicotine. But the idealists have adopted variants on the mantra “no teen should use nicotine.” Fine, that might be good advice. But what if they go further and try to make that a reality with various forms of prohibition, restrictions and misinformation? The trouble is that the much larger adult market will be bent out of shape by misguided efforts to protect youth. There will be more smoking, more illicit trade and more risky workarounds, including among youth. The realist goal of providing a lawful, acceptably safe, proportionally regulated nicotine market is undermined by the fervor of the idealists, with worse results for everyone.

    Third, the knockout blow. Collectively known as “endgame” measures, these grandiose schemes would abolish cigarettes as we know them, close nearly all retail outlets, impose shrinking production and import quotas, or ban sales to anyone born after a specific date. They have this in common: They won’t be implemented, they won’t work as expected, or they will have little useful effect. But they will obstruct the realists because these ideas divert political, regulatory, scientific capital and creativity into unworkable schemes and away from pragmatic, if humble, measures that will work. Worse, they occupy the imaginary sunlit uplands with a fake utopia, creating a mirage where there should be an achievable destination—a stable, lawful, well-regulated market for a popular drug.

    Fourth, the pursuit of paper tigers. I recently submitted evidence to an inquiry into new legislation in South Africa. The new law had been drafted as model anti-vaping legislation with extreme restrictions and penalties and tell-tale fingerprints of American activists. The contrast between the precision control, on paper, of the new law and the chaotic reality of South Africa’s giant illicit market is matched only by that of Australia’s new legislation that tries to ban vapes even harder, even though over 90 percent of the Australian vape market is already illegal. When the idealists declare a prohibition in law on paper, actual or de facto, it doesn’t make the banned products disappear. However, it does mean that more modest regulation becomes impossible because most of the market is unregulated and illicit.

    Fifth, why don’t they stop making cigarettes? A common idealist theme is that if tobacco companies are serious about health, they should just stop making cigarettes. It sounds superficially plausible and inspiring. In reality, these companies have a legal duty not to destroy their shareholders’ money. If they tried, three things would happen: The management would be fired, the company would be taken over, or the productive assets and brands would be sold as a going concern. All to no effect. The realists recognize the need for a transformation, moving the market to noncombustible nicotine products and diversifying the business into non-nicotine activities in which they have an advantage, keeping their shareholders on board throughout.

    Finally, conflicts of interest (COI). Idealists divide the world into independent and industry science. They see industry conflicts of interest as disqualifying from scholarly societies and journals. Yet, conflicts arise from every funding source or institution with policy preferences. An industry COI may be no more than a sign of having valuable marketable capabilities. The realists want to engage with anyone with specialized knowledge and, with due skepticism, to learn from their insights. The idealists prefer to erase them from the discourse and pursue purity at the expense of knowledge.

    To summarize, the idealists will resist the realists, and everything will be worse.